7096 — StemCell Institute Cashflow Statement
0.000.00%
Last trade - 00:00- ¥17bn
- ¥14bn
- ¥2bn
Annual cashflow statement for StemCell Institute, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 383 | 91.4 | 213 | 279 | 441 |
| Depreciation | |||||
| Non-Cash Items | 19.2 | 2.39 | 17.8 | 40 | -16.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 234 | 112 | 142 | -324 | -210 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 668 | 239 | 469 | 99.7 | 335 |
| Capital Expenditures | -65 | -403 | -204 | -59.9 | -202 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -43 | -117 | 609 | -225 | -610 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -108 | -520 | 404 | -285 | -812 |
| Financing Cash Flow Items | — | — | — | -0.001 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | 644 | -0.869 | -1.33 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 560 | -281 | 1,518 | -186 | -478 |